Clinical trials: People Without Neurocognitive Disorder
- Condition People Without Neurocognitive Disorder
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Alzheimer Disease
A Study of V950 in People With Alzheimer Disease (V950-001 AM7)
The purpose of this study is to test the safety, tolerability and the immune response to an investigational vaccine, V950, with or without ISCOMATRIX™ (IMX).
- Trial name
- NCT00464334
- Testing
- V950, ISCOMATRIX™
- Volunteers
- 86 people
- Sponsor
- Merck Sharp & Dohme LLC